Precision Optics Corporation Inc

Precision Optics Corporation Inc(POCI)股票分析

$4.887

-0.062 (-1.27%)收盘时

Loading chart…
最高
4.930
开盘
4.825
成交量加权均价
4.88
成交量
9.87K
市值
35.15M
最低
4.825
成交额
48.18K
企业价值/息税折旧摊销前利润(TTM)
-319.48

Precision Optics Corporation, Inc. is a developer and manufacturer of optical instruments. The Company’s segments include medical devices and advanced defense/aerospace products. Its optical and imaging technology, custom designs, manufacturing capabilities, and engineering and development capabilities have generated traditional endoscopes and endocouplers, digital imaging endoscopes using complementary metal-oxide-semiconductor (CMOS) sensor technology, some designed and manufactured for single-use, as well as other custom imaging and illumination products for our customers’ use in minimally invasive surgical procedures. It designs and manufactures precision endoscopes and microprecision lenses, assemblies and complete medical devices to meet the surgical community’s demand for imaging systems for minimally invasive surgery. Its technologies serve defense / aerospace markets, including applications supporting satellite network communications.

AI 分析 of Precision Optics Corporation Inc (POCI)

买入

Precision Optics Corporation Inc is a good buy right now due to its recent strong revenue growth, with Q3 revenue increasing by 107.1% year-over-year to $8.7 million, and a current price of $4.80, which is significantly below its 52-week high of $6.15. The RSI is at 80.676, indicating strong momentum, although it is approaching overbought levels. The main risk is the negative net income, which was -$103,787 in Q4 2026, but the trend is improving as the company moves towards profitability.

估值指标

Precision Optics Corporation Inc(POCI)当前预期市盈率为 0.00,5 年平均预期市盈率为 0.00。

预期市盈率

严重低估
5 年均值 P/E
0.00
当前P/E
0.00
高估
0.00
低估
0.00

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
307.03
当前EV/EBITDA
-319.48
高估
1354.40
低估
-740.33

预期市销率

严重高估
5 年均值 P/S
0.17
当前P/S
1.53
高估
0.64
低估
-0.31

Alphio AI 对 POCI 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%POCI

$4.83

情景价格

基

基准

基准 · 50%POCI

$4.56

情景价格

悲

悲观

悲观 · 25%POCI

$3.87

情景价格

事件时间线

2026-11-05 (ET)

10:30:00

Precision Optics Receives $2M Aerospace Order

2026-09-17 (ET)

09:30:00

Precision Optics Secures $50,000 Satellite Development Order

2026-09-10 (ET)

09:30:00

Precision Optics Receives $1.3M Follow-On Orders

2026-03-27 (ET)

07:50:00

Lucid Capital Offering Priced Below Last Closing Price of $4.21

2026-03-26 (ET)

16:10:00

Precision Optics Corporation Launches Underwritten Public Offering

资讯

POCI 常见问题 —— 由 Alphio AI 解答

Precision Optics Corporation, Inc. is a developer and manufacturer of optical instruments. The Company’s segments include medical devices and advanced defense/aerospace products. Its optical and imaging technology, custom designs, manufacturing capabilities, and engineering and development capabilities have generated traditional endoscopes and endocouplers, digital imaging endoscopes using complementary metal-oxide-semiconductor (CMOS) sensor technology, some designed and manufactured for single-use, as well as other custom imaging and illumination products for our customers’ use in minimally invasive surgical procedures. It designs and manufactures precision endoscopes and microprecision lenses, assemblies and complete medical devices to meet the surgical community’s demand for imaging systems for minimally invasive surgery. Its technologies serve defense / aerospace markets, including applications supporting satellite network communications. It operates in the Healthcare sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).

Precision Optics Corporation Inc is a good buy right now due to its recent strong revenue growth, with Q3 revenue increasing by 107.1% year-over-year to $8.7 million, and a current price of $4.80, which is significantly below its 52-week high of $6.15. The RSI is at 80.676, indicating strong momentum, although it is approaching overbought levels. The main risk is the negative net income, which was -$103,787 in Q4 2026, but the trend is improving as the company moves towards profitability.

暂无帖子

注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易